GSK Appoints CSO and President, R&D
By

By
GlaxoSmithKline has appointed Dr. Hal Barron as chief scientific officer, president, research and development (R&D), and executive director to the GSK Board of Directors. Barron will assume his new role…

US Senators Seek Additional Information on Allergan’s Use of Sovereign Immunity for Patents
By

By
A group of US Senators have sent a letter to Allergan’s chairman, president, and chief executive officer, Brenton Saunders, seeking further information about the company’s recent transfer of patents covering…

Pfizer Names Chief Operating Officer; Makes Other Senior Appointments
By

By
Pfizer has appointed Albert Bourla to the newly created position of chief operating officer, effective January 1, 2018.     Bourla has been the Group President of Pfizer’s Innovative Health Business since…

PCI Pharma Expands Highly Potent Drug-Product Capabilities
By

By
PCI Pharma Services, a pharmaceutical contract service provider, is investing in micro-dosing for highly potent active pharmaceutical ingredients using Xcelodose 600S technology at its center of excellence for contained manufacturing…

MilliporeSigma, Samsung BioLogics Extend Biomanufacturing Strategic Alliance
By

By
MilliporeSigma has signed a Memorandum of Understanding (MoU) with Samsung BioLogics, an Incheon, Korea-based contract biologics manufacturer, for biopharmaceutical manufacturing and biologics process development. The companies plan to accelerate process…

Lonza Launches Pichia Expression and Biomanufacturing Platform
By

By
Lonza has launched a new expression and manufacturing system, XS Pichia 2.0 Expression and Manufacturing Platform, for developing biotherapeutics. Pichia pastoris was designed as an alternative to E. coli and…

Cambrex Completes Small-Scale API Manufacturing Expansion
By

By
Cambrex, a contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), has completed an expansion of cGMP small-scale capacity at its plant in Charles City, Iowa. Under the project, two 500-gallon…

Grand River Aseptic Manufacturing Announces Investment by Private-Equity Firm
By

By
Grand River Aseptic Manufacturing, a Grand Rapids, Michigan-based provider of sterile-manufacturing services, has announced a new majority owner, Arlington Capital Partners, a private-equity firm based in the Washington, D.C. area.…

West Expands Operations in Germany
By

By
West Pharmaceutical Services, an Exton, Pennsylvania-headquartered manufacturer of packaging and delivery systems for injectable drugs and healthcare products, has opened the company’s expanded Kiefernweg Campus in Eschweiler, Germany. The expansion…

Evonik Launches Bioresorbable Polymers for Parenteral Drugs
By

By
Evonik is expanding its Resomer portfolio of bioresorbable polymers for controlled-release parenteral drug formulations. The company has launched Resomer Zero and Resomer Sterile versions of both its standard Resomer polymers…